Anne-fleur E. Schneider
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
In Vivo Phage Display for the Identification of Muscle Homing Peptides to Improve the Delivery of Phosphorodiamidate Morpholino Oligomers for Duchenne Muscular Dystrophy Therapy.
Journal: Nucleic acid therapeutics
Published: August 29, 2025
Guide to Selection of Muscle-Homing Peptides After in Vivo Phage Display Biopanning.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 28, 2025
A two-site collaborative study of electrical impedance myography for evaluation of disease progression in murine Duchenne muscular dystrophy models.
Journal: Scientific reports
Published: April 22, 2025
Using muscle homing peptide CyPep10 to deliver phosphorodiamidate morpholino oligomers in the mdx mouse.
Journal: Molecular therapy. Nucleic acids
Published: November 29, 2024
Identification of suitable qPCR reference genes for the normalization of gene expression in the BL10-mdx and D2-mdx mouse models of Duchenne muscular dystrophy.
Journal: PloS one
Published: November 12, 2024
A hidden layer of structural variation in transposable elements reveals potential genetic modifiers in human disease-risk loci.
Journal: Genome research
Published: March 14, 2021
Developments in reading frame restoring therapy approaches for Duchenne muscular dystrophy.
Journal: Expert opinion on biological therapy
Published: October 19, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026